These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23288025)

  • 1. C-terminal FGF23 fragments: present but not seen?
    Smith ER; McMahon LP; Holt SG
    Osteoporos Int; 2013 Jun; 24(6):1933-4. PubMed ID: 23288025
    [No Abstract]   [Full Text] [Related]  

  • 2. Intact fibroblast growth factor 23 and fragments in plasma from Gambian children.
    Braithwaite V; Bruggraber SF; Prentice A
    Osteoporos Int; 2013 Mar; 24(3):1121-4. PubMed ID: 22648001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23 is elevated in Gambian children with rickets.
    Prentice A; Ceesay M; Nigdikar S; Allen SJ; Pettifor JM
    Bone; 2008 Apr; 42(4):788-97. PubMed ID: 18234575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets.
    Bharati J; Bhatia D; Khandelwal P; Gupta N; Sinha A; Khadgawat R; Hari P; Bagga A
    Indian J Pediatr; 2019 Jun; 86(6):555-557. PubMed ID: 30835073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron status and fibroblast growth factor-23 in Gambian children.
    Braithwaite V; Jarjou LM; Goldberg GR; Prentice A
    Bone; 2012 Jun; 50(6):1351-6. PubMed ID: 22465847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets.
    Kubota T; Kitaoka T; Miura K; Fujiwara M; Ohata Y; Miyoshi Y; Yamamoto K; Takeyari S; Yamamoto T; Namba N; Ozono K
    Horm Res Paediatr; 2014; 81(4):251-7. PubMed ID: 24577200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
    Imel EA; Peacock M; Gray AK; Padgett LR; Hui SL; Econs MJ
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3541-9. PubMed ID: 21880793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact fibroblast growth factor-23 in plasma from Gambian children: response to the letter from Smith et al.
    Braithwaite V; Bruggraber SF; Prentice A
    Osteoporos Int; 2013 Jun; 24(6):1935-6. PubMed ID: 23288027
    [No Abstract]   [Full Text] [Related]  

  • 10. [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
    Michigami T
    Clin Calcium; 2013 Oct; 23(10):1429-35. PubMed ID: 24076640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
    Imel EA; Hui SL; Econs MJ
    J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
    Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
    Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rickets/Osteomalacia. Diagnosis of tumor-induced osteomalacia.].
    Koga M; Ito N
    Clin Calcium; 2018; 28(10):1351-1357. PubMed ID: 30269117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyostotic osteolysis and hypophosphatemic rickets with elevated serum fibroblast growth factor 23: A case report.
    Sato T; Muroya K; Asakura Y; Yachie A; Nishimura G; Aida N; Machida J; Tanaka Y; Hasegawa T; Adachi M
    Am J Med Genet A; 2015 Oct; 167A(10):2430-4. PubMed ID: 26059403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
    Kinoshita Y; Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujita T
    Eur J Endocrinol; 2012 Aug; 167(2):165-72. PubMed ID: 22577109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FGF23-related hypophosphatemic rickets/osteomalacia].
    Ito N; Fukumoto S
    Clin Calcium; 2007 Oct; 17(10):1514-20. PubMed ID: 17906402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Case Reports of FGF23-Induced Hypophosphatemia in Childhood Biliary Atresia.
    Wasserman H; Ikomi C; Hafberg ET; Miethke AG; Bove KE; Backeljauw PF
    Pediatrics; 2016 Aug; 138(2):. PubMed ID: 27462066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
    Endo I
    Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone and bone related biochemical examinations. Hormone and hormone related substances. The measurement of circulating fibroblast growth factor 23 (FGF-23)].
    Kobayashi K; Imanishi Y
    Clin Calcium; 2006 Jun; 16(6):935-39. PubMed ID: 16751688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rickets/Osteomalacia. FGF23-related hypophosphatemic rickets/osteomalacia.].
    Fukumoto S
    Clin Calcium; 2018; 28(10):1313-1317. PubMed ID: 30269112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.